References
- ADNI2. (2020). Alzheimer’s Disease neuroimaging initiative: ADNI2 procedures manual. Retrieved May 21, from https://adni.loni.usc.edu/wp-content/uploads/2008/07/adni2-procedures-manual.pdf
- Beach, T. G., Thal, D. R., Zanette, M., Smith, A., & Buckley, C. (2016). Detection of striatal amyloid plaques with [18F]flutemetamol: Validation with postmortem histopathology. Journal of Alzheimer’s Disease, 52(3), 863–873. https://doi.org/https://doi.org/10.3233/JAD-150732
- Bennett, D. A., Wilson, R. S., Schneider, J. A., Evans, D. A., Aggarwal, N. T., Arnold, S. E., Cochran, E. J., Berry-Kravis, E., & Bienias, J. L. (2003). Apolipoprotein E epsilon4 allele, AD pathology, and the clinical expression of Alzheimer’s disease. Neurology, 60(2), 246–252. https://doi.org/https://doi.org/10.1212/01.wnl.0000042478.08543.f7
- Biogen. (2020, August 7). 221AD302 phase 3 study of aducanumab (BIIB037) in Early Alzheimer’s Disease (EMERGE). US National Library of Medicine. https://clinicaltrials.gov/ct2/show/NCT02484547
- Bland, J. M., & Altman, D. G. (2011). Correlation in restricted ranges of data. Bmj, 342(mar11 1), d556. https://doi.org/https://doi.org/10.1136/bmj.d556
- Braak, H., & Braak, E. (1991). Neuropathological stageing of Alzheimer-related changes [Review]. Acta Neuropathologica, 82(4), 239–259. https://doi.org/https://doi.org/10.1007/BF00308809
- Burton, R. L., Enright, J., O’Connell, M. E., Lanting, S., & Morgan, D. (2015). RBANS embedded measures of suboptimal effort in dementia: Effort scale has a lower failure rate than the effort index [Research Support, Non-U.S. Gov’t]. Archives of Clinical Neuropsychology, 30(1), 1–6. https://doi.org/https://doi.org/10.1093/arclin/acu070
- Caldwell, J. Z. K., Berg, J. L., Cummings, J. L., & Banks, S. J., & Alzheimer’s Disease Neuroimaging, I. (2017). Moderating effects of sex on the impact of diagnosis and amyloid positivity on verbal memory and hippocampal volume. Alzheimer’s Research & Therapy, 9(1), 72. https://doi.org/https://doi.org/10.1186/s13195-017-0300-8
- Caselli, R. J., Dueck, A. C., Osborne, D., Sabbagh, M. N., Connor, D. J., Ahern, G. L., Baxter, L. C., Rapcsak, S. Z., Shi, J., Woodruff, B. K., Locke, D. E. C., Snyder, C. H., Alexander, G. E., Rademakers, R., & Reiman, E. M. (2009). Longitudinal modeling of age-related memory decline and the APOE ε4 effect. New England Journal of Medicine, 361(3), 255–263. https://doi.org/https://doi.org/10.1056/NEJMoa0809437
- Choe, Y. M., Sohn, B. K., Choi, H. J., Byun, M. S., Seo, E. H., Han, J. Y., Kim, Y. K., Yoon, E. J., Lee, J.-M., Park, J., Woo, J. I., & Lee, D. Y. (2014). Association of homocysteine with hippocampal volume independent of cerebral amyloid and vascular burden. Neurobiology of Aging, 35(7), 1519–1525. https://doi.org/https://doi.org/10.1016/j.neurobiolaging.2014.01.013
- Clark, J. H., Hobson, V. L., & O’Bryant, S. E. (2010). Diagnostic accuracy of percent retention scores on RBANS verbal memory subtests for the diagnosis of Alzheimer’s disease and mild cognitive impairment [Comparative Study]. Archives of Clinical Neuropsychology, 25(4), 318–326. https://doi.org/https://doi.org/10.1093/arclin/acq023
- Cooley, S. A., Heaps, J. M., Bolzenius, J. D., Salminen, L. E., Baker, L. M., Scott, S. E., & Paul, R. H. (2015). Longitudinal change in performance on the montreal cognitive assessment in older adults [Research Support, N.I.H., Extramural]. The Clinical Neuropsychologist, 29(6), 824–835. https://doi.org/https://doi.org/10.1080/13854046.2015.1087596
- Cosentino, S., Scarmeas, N., Helzner, E., Glymour, M. M., Brandt, J., Albert, M., Blacker, D., & Stern, Y. (2008). APOE epsilon 4 allele predicts faster cognitive decline in mild Alzheimer disease. Neurology, 70(19 Pt 2), 1842–1849. https://doi.org/https://doi.org/10.1212/01.wnl.0000304038.37421.cc
- De Jager, C. A., Hogervorst, E., Combrinck, M., & Budge, M. M. (2003). Sensitivity and specificity of neuropsychological tests for mild cognitive impairment, vascular cognitive impairment and Alzheimer’s disease. Psychological Medicine, 33(6), 1039–1050. https://doi.org/https://doi.org/10.1017/s0033291703008031
- Duff, K., Foster, N. L., Dennett, K., Hammers, D. B., Zollinger, L. V., Christian, P. E., Butterfield, R. I., Beardmore, B. E., Wang, A. Y., Morton, K. A., & Hoffman, J. M. (2013). Amyloid deposition and cognition in older adults: The effects of premorbid intellect. Archives of Clinical Neuropsychology, 28(7), 665–671. https://doi.org/https://doi.org/10.1093/arclin/act047
- Duff, K., Hobson, V. L., Beglinger, L. J., & O’Bryant, S. E. (2010). Diagnostic accuracy of the RBANS in mild cognitive impairment: Limitations on assessing milder impairments. Archives of Clinical Neuropsychology, 25(5), 429–441. https://doi.org/https://doi.org/10.1093/arclin/acq045
- Duff, K., Humphreys Clark, J. D., O’Bryant, S. E., Mold, J. W., Schiffer, R. B., & Sutker, P. B. (2008). Utility of the RBANS in detecting cognitive impairment associated with Alzheimer’s disease: Sensitivity, specificity, and positive and negative predictive powers. Archives of Clinical Neuropsychology, 23(5), 603–612. https://doi.org/https://doi.org/10.1016/j.acn.2008.06.004
- Duff, K., & Ramezani, A. (2015). Regression-based normative formulae for the repeatable battery for the assessment of neuropsychological status for older adults. Archives of Clinical Neuropsychology, 30(7), 600–604. https://doi.org/https://doi.org/10.1093/arclin/acv052
- England, H. B., Gillis, M. M., & Hampstead, B. M. (2014). RBANS memory indices are related to medial temporal lobe volumetrics in healthy older adults and those with mild cognitive impairment [Research Support, N.I.H., Extramural Research Support, U.S. Gov’t, Non-P.H.S.]. Archives of Clinical Neuropsychology, 29(4), 322–328. https://doi.org/https://doi.org/10.1093/arclin/acu012
- Enright, J., O’Connell, M. E., MacKinnon, S., & Morgan, D. G. (2015). Predictors of completion of executive-functioning tasks in a memory clinic dementia sample [Research Support, Non-U.S. Gov’t]. Applied Neuropsychology: Adult, 22(6), 459–464. https://doi.org/https://doi.org/10.1080/23279095.2014.992070
- Falgas, N., Sanchez-Valle, R., Bargallo, N., Balasa, M., Fernandez-Villullas, G., Bosch, B., Llado, A., Antonell, A., Muñoz-García, C., León, M., Grau, O., Castellví, M., Coll-Padrós, N., Rami, L., Redolfi, A., Lladó, A., & Olives, J. (2019). Hippocampal atrophy has limited usefulness as a diagnostic biomarker on the early onset Alzheimer’s disease patients: A comparison between visual and quantitative assessment. NeuroImage: Clinical, 23, 101927. https://doi.org/https://doi.org/10.1016/j.nicl.2019.101927
- Fischl, B., & Dale, A. M. (2000). Measuring the thickness of the human cerebral cortex from magnetic resonance images. Proceedings of the National Academy of Sciences, 97(20), 11050–11055. https://doi.org/https://doi.org/10.1073/pnas.200033797
- Fischl, B., Salat, D. H., Busa, E., Albert, M., Dieterich, M., Haselgrove, C., van der Kouwe, A., Killiany, R., Kennedy, D., Klaveness, S., Montillo, A., Makris, N., Rosen, B., & Dale, A. M. (2002). Whole brain segmentation: Automated labeling of neuroanatomical structures in the human brain. Neuron, 33(3), 341–355. https://doi.org/https://doi.org/10.1016/s0896-6273(02)00569-x
- Fischl, B., van der Kouwe, A., Destrieux, C., Halgren, E., Segonne, F., Salat, D. H., & Dale, A. M. (2004). Automatically parcellating the human cerebral cortex. Cerebral Cortex, 14(1), 11–22. https://doi.org/https://doi.org/10.1093/cercor/bhg087
- Folstein, M. F., Folstein, S. E., & McHugh, P. R. (1975). “Mini-mental state.” A practical method for grading the cognitive state of patients for the clinician. Journal of Psychiatric Research, 12(3), 189–198. https://doi.org/https://doi.org/10.1016/0022-3956(75)90026-6
- Frisoni, G. B., Fox, N. C., Jack, C. R., Jr., Scheltens, P., & Thompson, P. M. (2010). The clinical use of structural MRI in Alzheimer disease. Nature Reviews Neurology, 6(2), 67–77. https://doi.org/https://doi.org/10.1038/nrneurol.2009.215
- Ge, T., Sabuncu, M. R., Smoller, J. W., Sperling, R. A., & Mormino, E. C., & Alzheimer’s Disease Neuroimaging, I. (2018). Dissociable influences of APOE epsilon4 and polygenic risk of AD dementia on amyloid and cognition. Neurology, 90(18), e1605–e1612. doi:https://doi.org/10.1212/WNL.0000000000005415.
- Gibbons, L. E., Carle, A. C., Mackin, R. S., Harvey, D., Mukherjee, S., Insel, P., Curtis, S. M., Mungas, D., & Crane, P. K., & Alzheimer’s Disease Neuroimaging, I. (2012). A composite score for executive functioning, validated in Alzheimer’s Disease Neuroimaging Initiative (ADNI) participants with baseline mild cognitive impairment. Brain Imaging and Behavior, 6(4), 517–527. https://doi.org/https://doi.org/10.1007/s11682-012-9176-1
- Hammers, D. B., Atkinson, T. J., Dalley, B. C., Suhrie, K. R., Beardmore, B. E., Burrell, L. D., Horn, K. P., Rasmussen, K. M., Foster, N. L., Duff, K., & Hoffman, J. M. (2017). Relationship between 18F-Flutemetamol uptake and RBANS performance in non-demented community-dwelling older adults. The Clinical Neuropsychologist, 31(3), 531–543. https://doi.org/https://doi.org/10.1080/13854046.2016.1278039
- Hammers, D. B., Atkinson, T. J., Dalley, B. C. A., Suhrie, K. R., Horn, K. P., Rasmussen, K. M., Beardmore, B. E., Burrell, L. D., Duff, K., & Hoffman, J. M. (2017). Amyloid positivity using [18F]Flutemetamol-PET and cognitive deficits in nondemented community-dwelling older adults. American Journal of Alzheimer’s Disease & Other Dementiasr, 32(6), 320–328. https://doi.org/https://doi.org/10.1177/1533317517698795
- Hammers, D. B., Foster, N. L., Hoffman, J. M., Greene, T. H., & Duff, K. (2019). Neuropsychological, psychiatric, and functional correlates of clinical trial enrollment. The Journal of Prevention of Alzheimer’s Disease, 6(4), 242–247. https://doi.org/https://doi.org/10.14283/jpad.2019.38
- Heyanka, D. J., Scott, J. G., & Adams, R. L. (2015). Improving the diagnostic accuracy of the RBANS in mild cognitive impairment with construct-consistent measures. Applied Neuropsychology: Adult, 22(1), 32–41. https://doi.org/https://doi.org/10.1080/23279095.2013.827574
- Hobson, V. L., Hall, J. R., Humphreys-Clark, J. D., Schrimsher, G. W., & O’Bryant, S. E. (2010). Identifying functional impairment with scores from the repeatable battery for the assessment of neuropsychological status (RBANS). International Journal of Geriatric Psychiatry, 25(5), 525–530. https://doi.org/https://doi.org/10.1002/gps.2382
- Holtzman, D. M., Herz, J., & Bu, G. (2012). Apolipoprotein E and apolipoprotein E receptors: Normal biology and roles in Alzheimer disease. Cold Spring Harbor Perspectives in Medicine, 2(3), a006312. https://doi.org/https://doi.org/10.1101/cshperspect.a006312
- Hyman, B. T., Van Hoesen, G. W., & Damasio, A. R. (1990). Memory-related neural systems in Alzheimer’s disease: An anatomic study [Research Support, Non-U.S. Gov’t Research Support, U.S. Gov’t, P.H.S.]. Neurology, 40(11), 1721–1730. https://doi.org/https://doi.org/10.1212/WNL.40.11.1721
- Insel, P. S., Mattsson, N., Mackin, R. S., Kornak, J., Nosheny, R., Tosun-Turgut, D., Donohue, M. C., Aisen, P. S., & Weiner, M. W., & Alzheimer’s Disease Neuroimaging, I. (2015). Biomarkers and cognitive endpoints to optimize trials in Alzheimer’s disease. Annals of Clinical and Translational Neurology, 2(5), 534–547. https://doi.org/https://doi.org/10.1002/acn3.192
- Jack, C. R., Jr., Wiste, H. J., Weigand, S. D., Knopman, D. S., Vemuri, P., Mielke, M. M., Lowe, V., Senjem, M. L., Gunter, J. L., Machulda, M. M., Gregg, B. E., Pankratz, V. S., Rocca, W. A., & Petersen, R. C. (2015). Age, Sex, and APOE ε4 effects on memory, brain structure, and β-Amyloid across the adult life span. JAMA Neurology, 72(5), 511–519. https://doi.org/https://doi.org/10.1001/jamaneurol.2014.4821
- Jiang, L., Cheng, Y., Li, Q., Tang, Y., Shen, Y., Li, T., Li, Q., Li, T., Feng, W., Cao, X., Wu, W., Wang, J., & Li, C. (2014). Cross-sectional study of the association of cognitive function and hippocampal volume among healthy elderly adults. Shanghai archives of Psychiatry, 26(5), 280–287. https://doi.org/https://doi.org/10.11919/j.1002-0829.214036
- Karantzoulis, S., Novitski, J., Gold, M., & Randolph, C. (2013). The repeatable battery for the assessment of neuropsychological status (RBANS): Utility in detection and characterization of mild cognitive impairment due to Alzheimer’s disease [Evaluation Studies Multicenter Study]. Archives of Clinical Neuropsychology, 28(8), 837–844. https://doi.org/https://doi.org/10.1093/arclin/act057
- Kim, J., Basak, J. M., & Holtzman, D. M. (2009). The role of apolipoprotein E in Alzheimer’s disease. Neuron, 63(3), 287–303. https://doi.org/https://doi.org/10.1016/j.neuron.2009.06.026
- Kim, J. S. (2020). Tau imaging: New era of neuroimaging for Alzheimer’s Disease. Nuclear Medicine and Molecular Imaging, 54(4), 161–162. https://doi.org/https://doi.org/10.1007/s13139-020-00657-4
- Lim, Y. Y., Williamson, R., Laws, S. M., Villemagne, V. L., Bourgeat, P., Fowler, C., … Group, A. R. (2017). Effect of APOE genotype on amyloid deposition, brain volume, and memory in cognitively normal older individuals. Journal of Alzheimer’s Disease, 58(4), 1293–1302. https://doi.org/https://doi.org/10.3233/JAD-170072
- Lundqvist, R., Lilja, J., Thomas, B. A., Lotjonen, J., Villemagne, V. L., Rowe, C. C., & Thurfjell, L. (2013). Implementation and validation of an adaptive template registration method for 18F-flutemetamol imaging data. Journal of Nuclear Medicine, 54(8), 1472–1478. https://doi.org/https://doi.org/10.2967/jnumed.112.115006
- Mayeux, R., Stern, Y., Ottman, R., Tatemichi, T. K., Tang, M. X., Maestre, G., Ngai, C., Tycko, B., & Ginsberg, H. (1993). The apolipoprotein epsilon 4 allele in patients with Alzheimer’s disease. Annals of Neurology, 34(5), 752–754. https://doi.org/https://doi.org/10.1002/ana.410340527
- McDermott, A. T., & DeFilippis, N. A. (2010). Are the indices of the RBANS sufficient for differentiating Alzheimer’s disease and subcortical vascular dementia? Archives of Clinical Neuropsychology, 25(4), 327–334. https://doi.org/https://doi.org/10.1093/arclin/acq028
- Morgan, D. R., Linck, J., Scott, J., Adams, R., & Mold, J. (2010). Assessment of the RBANS Visual and Verbal Indices in a sample of neurologically impaired elderly participants. The Clinical Neuropsychologist, 24(8), 1365–1378. https://doi.org/https://doi.org/10.1080/13854046.2010.516769
- Mormino, E. C., Betensky, R. A., Hedden, T., Schultz, A. P., Amariglio, R. E., Rentz, D. M., … Sperling, R. A. (2014). Synergistic effect of beta-amyloid and neurodegeneration on cognitive decline in clinically normal individuals. JAMA Neurology, 71(11), 1379–1385. https://doi.org/https://doi.org/10.1001/jamaneurol.2014.2031
- Morris, J. C. (1993). The Clinical Dementia Rating (CDR): Current version and scoring rules. Neurology, 43(11), 2412–2414. https://doi.org/https://doi.org/10.1212/WNL.43.11.2412-a
- O’Mahar, K. M., Duff, K., Scott, J. G., Linck, J. F., Adams, R. L., & Mold, J. W. (2012). Brief report: The temporal stability of the Repeatable Battery for the Assessment of Neuropsychological Status Effort Index in geriatric samples [Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov’t]. Archives of Clinical Neuropsychology, 27(1), 114–118. https://doi.org/https://doi.org/10.1093/arclin/acr072
- Ottoy, J., Niemantsverdriet, E., Verhaeghe, J., De Roeck, E., Struyfs, H., Somers, C., … Staelens, S. (2019). Association of short-term cognitive decline and MCI-to-AD dementia conversion with CSF, MRI, amyloid- and (18)F-FDG-PET imaging. NeuroImage: Clinical, 22, 101771. https://doi.org/https://doi.org/10.1016/j.nicl.2019.101771
- Paul, R., Lane, E. M., Tate, D. F., Heaps, J., Romo, D. M., Akbudak, E., Niehoff, J., & Conturo, T. E. (2011). Neuroimaging signatures and cognitive correlates of the Montreal cognitive assessment screen in a nonclinical elderly sample [Research Support, N.I.H., Extramural]. Archives of Clinical Neuropsychology, 26(5), 454–460. https://doi.org/https://doi.org/10.1093/arclin/acr017
- Petersen, R. C., Jack, C. R., Jr., Xu, Y. C., Waring, S. C., O’Brien, P. C., Smith, G. E., Ivnik, R. J., Tangalos, E. G., Boeve, B. F., & Kokmen, E. (2000). Memory and MRI-based hippocampal volumes in aging and AD. Neurology, 54(3), 581–587. https://doi.org/https://doi.org/10.1212/wnl.54.3.581
- Petersen, R. C., Smith, G. E., Ivnik, R. J., Tangalos, E. G., Schaid, D. J., Thibodeau, S. N., & Kurland, L. T. (1995). Apolipoprotein E status as a predictor of the development of Alzheimer’s disease in memory-impaired individuals. JAMA: The Journal of the American Medical Association, 273(16), 1274–1278. https://doi.org/https://doi.org/10.1001/jama.1995.03520400044042
- Phillips, R., Qi, G., Collinson, S. L., Ling, A., Feng, L., Cheung, Y. B., & Ng, T. P. (2015). The minimum clinically important difference in the repeatable battery for the assessment of neuropsychological status. The Clinical Neuropsychologist, 29(7), 905–923. https://doi.org/https://doi.org/10.1080/13854046.2015.1107137
- Randolph, C. (2012). Repeatable battery for the assessment of neuropsychological status. The Psychological Corporation.
- Salthouse, T. A. (2009). Decomposing age correlations on neuropsychological and cognitive variables. Journal of the International Neuropsychological Society, 15(5), 650–661. https://doi.org/https://doi.org/10.1017/S1355617709990385
- Schmitt, A. L., Livingston, R. B., Smernoff, E. N., Reese, E. M., Hafer, D. G., & Harris, J. B. (2010). Factor analysis of the repeatable battery for the assessment of neuropsychological status (RBANS) in a large sample of patients suspected of dementia. Applied Neuropsychology, 17(1), 8–17. https://doi.org/https://doi.org/10.1080/09084280903297719
- Small, B. J., Rosnick, C. B., Fratiglioni, L., & Backman, L. (2004). Apolipoprotein E and cognitive performance: A meta-analysis. Psychology and Aging, 19(4), 592–600. https://doi.org/https://doi.org/10.1037/0882-7974.19.4.592
- Sunderland, J. J., & Christian, P. E. (2015). Quantitative PET/CT scanner performance characterization based upon the society of nuclear medicine and molecular imaging clinical trials network oncology clinical simulator phantom. Journal of Nuclear Medicine, 56(1), 145–152. https://doi.org/https://doi.org/10.2967/jnumed.114.148056
- Teng, E., Ward, M., Manser, P. T., Sanabria-Bohorquez, S., Ray, R. D., Wildsmith, K. R., Baker, S., Kerchner, G. A., & Weimer, R. M. (2019). Cross-sectional associations between [(18)F]GTP1 tau PET and cognition in Alzheimer’s disease. Neurobiology of Aging, 81, 138–145. https://doi.org/https://doi.org/10.1016/j.neurobiolaging.2019.05.026
- Thaler, N. S., Hill, B. D., Duff, K., Mold, J., & Scott, J. G. (2015). Repeatable battery for the assessment of neuropsychological status (RBANS) intraindividual variability in older adults: Associations with disease and mortality. Journal of Clinical and Experimental Neuropsychology, 37(6), 622–629. https://doi.org/https://doi.org/10.1080/13803395.2015.1039962
- Thurfjell, L., Lilja, J., Lundqvist, R., Buckley, C., Smith, A., Vandenberghe, R., & Sherwin, P. (2014). Automated quantification of 18F-flutemetamol PET activity for categorizing scans as negative or positive for brain amyloid: Concordance with visual image reads. Journal of Nuclear Medicine, 55(10), 1623–1628. https://doi.org/https://doi.org/10.2967/jnumed.114.142109
- Troyer, A. K., Murphy, K. J., Anderson, N. D., Craik, F. I., Moscovitch, M., Maione, A., & Gao, F. (2012). Associative recognition in mild cognitive impairment: Relationship to hippocampal volume and apolipoprotein E. Neuropsychologia, 50(14), 3721–3728. https://doi.org/https://doi.org/10.1016/j.neuropsychologia.2012.10.018
- U.S. Bureau of Labor Statistics. (2016). Volunteering in the United States, 2015 https://www.bls.gov/news.release/volun.nr0.htm
- Van Hoesen, G. W., Hyman, B. T., & Damasio, A. R. (1991). Entorhinal cortex pathology in Alzheimer’s disease [Research Support, Non-U.S. Gov’t Research Support, U.S. Gov’t, P.H.S. Review]. Hippocampus, 1(1), 1–8. https://doi.org/https://doi.org/10.1002/hipo.450010102
- Vandenberghe, R., Van Laere, K., Ivanoiu, A., Salmon, E., Bastin, C., Triau, E., Hasselbalch, S., Law, I., Andersen, A., Korner, A., Minthon, L., Garraux, G., Nelissen, N., Bormans, G., Buckley, C., Owenius, R., Thurfjell, L., Farrar, G., & Brooks, D. J. (2010). 18F-flutemetamol amyloid imaging in Alzheimer disease and mild cognitive impairment: A phase 2 trial. Annals of Neurology, 68(3), 319–329. https://doi.org/https://doi.org/10.1002/ana.22068
- Villemagne, V. L., & Okamura, N. (2016). Tau imaging in the study of ageing, Alzheimer’s disease, and other neurodegenerative conditions. Current Opinion in Neurobiology, 36, 43–51. https://doi.org/https://doi.org/10.1016/j.conb.2015.09.002
- Wechsler, D. (1987). Manual for the Weschler Memory Scale - Revised. The Psychological Corporation.
- Wessels, A. M., Tariot, P. N., Zimmer, J. A., Selzler, K. J., Bragg, S. M., Andersen, S. W., … Sims, J. R. (2020). Efficacy and safety of lanabecestat for treatment of early and mild Alzheimer Disease: The AMARANTH and DAYBREAK-ALZ randomized clinical trials. JAMA Neurology, 77(2), 199–209. https://doi.org/https://doi.org/10.1001/jamaneurol.2019.3988
- Wilkinson, G. S., & Robertson, G. J. (2006). WRAT 4: Wide range achievement test, professional manual. Psychological Assessment Resources, Inc.
- Wolk, D. A., Price, J. C., Saxton, J. A., Snitz, B. E., James, J. A., Lopez, O. L., … De-Kosky, S. T. (2009). Amyloid imaging in mild cognitive impairment subtypes. Annals of Neurology, 65(5), 557–568. https://doi.org/https://doi.org/10.1002/ana.21598
- Wu, L., Rowley, J., Mohades, S., Leuzy, A., Dauar, M. T., Shin, M., … Rosa-Neto, P. (2012). Dissociation between brain amyloid deposition and metabolism in early mild cognitive impairment [Clinical Trial Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov’t]. PLoS One, 7(10), e47905. https://doi.org/https://doi.org/10.1371/journal.pone.0047905
- Yesavage, J. A., Brink, T. L., Rose, T. L., Lum, O., Huang, V., Adey, M., & Leirer, V. O. (1982). Development and validation of a geriatric depression screening scale: A preliminary report. Journal of Psychiatric Research, 17(1), 37–49. https://doi.org/https://doi.org/10.1016/0022-3956(82)90033-4
- Yester, M., Al-Senan, R., & White, S. (2014). NEMA testing of GE Discovery 710 PET scanner compared to a simplified protocol for routine testing of PET scanners. Journal of Nuclear Medicine, 55, 2157.
- Rabipour S, Rajagopal S, Yu E, Pasvanis S, Lafaille-Magnan ME, Breitner J; PREVENT-AD Research Group, and Rajah MN. APOE4 Status is Related to Differences in Memory-Related Brain Function in Asymptomatic Older Adults with Family History of Alzheimer's Disease: Baseline Analysis of the PREVENT-AD Task Functional MRI Dataset. J Alzheimers Dis. 2020;76(1):97–119.